Beukers M W, Kerkhof C J, van Rhee M A, Ardanuy U, Gurgel C, Widjaja H, Nickel P, IJzerman A P, Soudijn W
Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry.
Naunyn Schmiedebergs Arch Pharmacol. 1995 May;351(5):523-8. doi: 10.1007/BF00171044.
Ecto-nucleotidases are plasma membrane-bound enzymes that sequentially dephosphorylate extracellular nucleotides such as ATP. This breakdown of ATP and other nucleotides obscures the characterization and classification of P2 (nucleotide) receptors. We therefore studied suramin and several of its analogs, divalent cations and ATP gamma S for their ability to inhibit ecto-ATPase in human blood cells. Suramin itself and Ni2+ were the more potent, non-competitive inhibitors with micromolar affinity. ATP gamma S also displayed micromolar affinity and inhibited ecto-ATPase competitively. The data obtained with the divalent cations demonstrate that coordination of the phosphate chain but not the N7 of the adenine ring is required for the breakdown of ATP by ecto-ATPase. Divalent cations that coordinate both the phosphate chain and N7 inhibit ecto-ATPase in a non-competitive manner.
外核苷酸酶是结合在质膜上的酶,可依次使细胞外核苷酸(如ATP)去磷酸化。ATP和其他核苷酸的这种分解模糊了P2(核苷酸)受体的特征和分类。因此,我们研究了苏拉明及其几种类似物、二价阳离子和ATPγS抑制人血细胞中外ATP酶的能力。苏拉明本身和Ni2+是更有效的非竞争性抑制剂,具有微摩尔亲和力。ATPγS也显示出微摩尔亲和力,并竞争性抑制外ATP酶。用二价阳离子获得的数据表明,外ATP酶分解ATP需要磷酸链的配位,而不是腺嘌呤环的N7。同时配位磷酸链和N7的二价阳离子以非竞争性方式抑制外ATP酶。